FoxP3-expressing T regulatory cells in atopic dermatitis lesions

被引:21
作者
Caproni, Marzia
Antiga, Emiliano
Torchia, Daniele
Volpi, Walter
Barletta, Ernanuela
Gitti, Gianni
De Campora, Enrico
Fabbri, Paolo
机构
[1] Univ Florence, Dept Dermatol Sci, Florence, Italy
[2] Univ Florence, Dept Expt Pathol & Oncol, Florence, Italy
[3] Univ Florence, Dept Surg Oto Neuro Ophthalmol Sci, Florence, Italy
关键词
atopic dermatitis; CD25; double immunostaining; FoxP3; immune regulation; immunohistochemistry; T regulatory cells;
D O I
10.2500/aap2007.28.3043
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Recently, studies were conducted to evaluate the impact of T regulatory (T regs) cells in the pathophysiology of atopic dermatitis (AD). The aim of this study was to investigate whether natural T regs are present in AD skin lesions. We performed skin biopsies in 12 adult patients affected by moderate-to-severe AD and 4 healthy volunteers. The specimens were stained immunohistochemically with anti-human CD25 and forkhead/winged helix transcription factor (FoxP3). Double immunostaining for CD25 and FoxP3 was performed also. CD25(+) cells strongly infiltrated the perivascular and papillar dermis of all lesional specimens, and FoxP3(+) cells were distributed in the perivascular and interstitial AD dermis, and some cells also infiltrated the dermoepidermal junction and the basal and suprabasal epidermal layers. All healthy skin specimens showed weak CD25 and FoxP3 stainings. Double immunostaining showed that CD25(+) FoxP3(+) cells were distributed in the perivascular, interstitial, and periadnexal dermis, and healthy skin specimens featured few CD25(+) FoxP3(+) cells scattered throughout the dermis. The past and present data show that an impaired function of natural T regs may not play a primary role in the pathophysiology of AD lesions.
引用
收藏
页码:525 / 528
页数:4
相关论文
共 11 条
[1]   Atopic dermatitis is associated with a low-producer transforming growth factor β1 cytokine genotype [J].
Arkwright, PD ;
Chase, JM ;
Babbage, S ;
Pravica, V ;
David, TJ ;
Hutchinson, IV .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 108 (02) :281-+
[2]   Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials [J].
Ashcroft, DM ;
Dimmock, P ;
Garside, R ;
Stein, K ;
Williams, HC .
BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7490) :516-522
[3]   Natural versus adaptive regulatory T cells [J].
Bluestone, JA ;
Abbas, AK .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) :253-257
[4]  
Boguniewicz M, 2004, ALLERGY ASTHMA PROC, V25, P279
[5]   The effects of tacrolimus ointment on regulatory T lymphocytes in atopic dermatitis [J].
Caproni, Marzia ;
Torchia, Daniele ;
Antiga, Emiliano ;
Volpi, Walter ;
Del Bianco, Elena ;
Fabbri, Paolo .
JOURNAL OF CLINICAL IMMUNOLOGY, 2006, 26 (04) :370-375
[6]   Immune dysregulation in atopic dermatitis [J].
del Giudice, Michele Miraglia ;
Decimo, Fabio ;
Leonardi, Salvatore ;
Maioello, Nunzia ;
Amelio, Raffaele ;
Capasso, Antonella ;
Capristo, Carlo ;
Capristo, Angelo F. .
ALLERGY AND ASTHMA PROCEEDINGS, 2006, 27 (06) :451-455
[7]   Spontaneous expression of mRNA for IL-10, GM-CSF, TGF-β, TNF-α, and IL-6 in peripheral blood mononuclear cells from atopic dermatitis [J].
Lee, HJ ;
Lee, HP ;
Ha, SJ ;
Byun, DG ;
Kim, JW .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2000, 84 (05) :553-558
[8]   T regulatory cells in atopic dermatitis and subversion of their activity by superantigens [J].
Ou, LS ;
Goleva, E ;
Hall, C ;
Leung, DYM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (04) :756-763
[9]  
Rico MJ, 2002, ALLERGY ASTHMA PROC, V23, P191
[10]   Absence of T-regulatory cell expression and function in atopic dermatitis skin [J].
Verhagen, J ;
Akdis, M ;
Traidl-Hoffmann, C ;
Schmid-Grendelmeier, P ;
Hijnen, D ;
Knol, EF ;
Behrendt, H ;
Blaser, K ;
Akdis, CA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (01) :176-183